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regression, three stable, three moderate), 16 PG (four regression,
four stable, four moderate), 17 LAVVR (six regression, seven stable,
four moderate). Image quality of micro-TEE was scored 1 for 2D and
2 for Doppler. In three patients on circulatory assistance, micro-TEE
could be performed in PICU with good tolerance and acceptable
quality.
Conclusions.— TEE is a tool to evaluate hemodynamic signiﬁcance
of post-operative residual lesions. This new microprobe offers the
possibility to perform TEE in small infants in the OR and in unstable
patients with poor imaging TTE in PICU.
http://dx.doi.org/10.1016/j.acvd.2013.06.006
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Background.— Coronary compression (CC) may occur during per-
cutaneous pulmonary valve implantation (PPVI) and is potentially
life threatening when undiagnosed before right ventricular outﬂow
tract (RVOT) stenting. We sought to evaluate its incidence, diagnosis
and outcome.
Methods.— All consecutive patients who underwent transcatheter
RVOT treatment from May 2008 to December 2011 in two institutions
were studied. Baseline demographics, diagnosis and outcomes of CC
were reviewed with analysis of risk factors.
Results.— CC occurred in six out of 100 patients (6%) at a median
age of 24 (13 to 49) years, with RVOT conduit stenosis as the
primary lesion in all cases. The initial congenital heart disease
was pulmonary atresia-ventricular septal defect (n = 3), complex
transposition of the great arteries (n = 2) and critical aortic steno-
sis status-post Ross operation (n = 1). The RVOT initial median
conduit diameter at surgical implantation was 23 (17 to 24) mm
and conduit types were homograft (n = 3), bioprothesis (n = 2) and a
pericardial patch (n = 1). CC was diagnosed by coronary angiogram
during balloon dilation of the RVOT in all cases whereas it was
suspected on pre-procedure computed tomography (CT-scan) in
only two cases. Compression occurred on the left anterior des-
cending coronary artery in four cases and on a right coronary
artery that arose from the proximal left anterior descending coro-
nary artery in two patients (single coronary artery). No risk factor
was found but there was a signiﬁcantly higher incidence of CC
in one of the two institutions (P = 0.04). CC was well-tolerated
and resolved after the balloon was deﬂated in all the cases. No
patients underwent RVOT stenting or PPVI. Surgical conduit replace-
ment was electively performed in three patients. Two patients with
moderate residual RVOT stenosis are followed. One patient with
encephalopathy and respiratory insufﬁciency died 9months after
catheterization.
Conclusions.— CC is efﬁciently diagnosed by coronary angiogram
during balloon dilation in patients undergoing transcatheter
interventions on RVOT. Diagnosis by pre-procedure CT-scan is
not accurate. No speciﬁc risk factors exist. Surgical conduit
replacement is indicated when balloon dilation fails to improve the
RVOT obstruction.
http://dx.doi.org/10.1016/j.acvd.2013.06.007
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Background.— Patent ductus arteriosus is responsible for left ven-
tricular diastolic and right ventricular systolic overload. Little is
known about hemodynamic changes after percutaneous and surgical
closure.
Methods.— We conducted a bicentric prospective study, of chil-
dren, with patent ductus arteriosus, evaluating the evolution
of systolic and diastolic ventricular function before, 1 day and
1month after successful closure, by means of transthoracic
echocardiography.
Results.— Thirty-three children, age 3months to 14.5 years, under-
went successful closure of their patent ductus arteriosus, 32
percutaneously and one surgically. All patent ductus arteriosus
were closed for hemodynamic reasons, with a mean diame-
ter of 3.6± 0.9mm. There was a signiﬁcant increase in systolic
(100.6± 15.1 versus 95.4± 15.3mmHg, P < 0.05) and diastolic
(53.2± 17.1 versus 47.8± 17.2mmHg, P < 0.05) blood pressures,
immediately after the suppression of the shunt. Left ventricu-
lar fractional shortening and end-diastolic volumes index were
signiﬁcantly lower the day after closure (respectively 34.7± 5.5
versus 37.8± 4.7% and 47± 16.2 versus 54.6± 20.1mL/m2) and
remained low compared to the preclosure state at follow-up
(respectively 33.8± 5.4 versus 37.8± 4.7% and 47± 12.7 versus
54.6± 20.1mL/m2). A non-signiﬁcant decrease in left ventricular
ﬁlling pressures was observed. Right ventricular systolic parameters
(TAPSE) were signiﬁcantly lower 1month after closure (19.3± 2.9
versus 21.4± 4.4mm, P < 0.05).
Conclusion.— Changes in left ventricular volume and function and
in right ventricular function occur immediately after patent duc-
tus arteriosus closure, and remain at 1month of follow-up. Further
studies are warranted to increase the number of patients and the
duration of follow-up.
http://dx.doi.org/10.1016/j.acvd.2013.06.008
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Objectives.— To describe the aims and rationale for planned deliv-
ery in a tertiary referral centre for foetuses with prenatal diagnosis
of congenital heart disease.
Methods and results.— Two thousand one hundred and thirty con-
secutive foetuses with congenital heart disease diagnosed from
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January 2002 to December 2011 were included: 1258 (59%) in-born
neonates whose delivery was planned in our institution, 799 (38%)
terminations of pregnancy, and 73 (3%) foetal deaths. For in-born,
planned delivery was classiﬁed as ‘certainly justiﬁed’ for 899 (71%)
for the following reasons: Rashkind atrioseptotomy in 344 cases,
risk of aortic coarctation in 272 cases, ductal patency needed for
pulmonary ﬂow in 107 cases, ductal patency needed for systemic
ﬂow in 93 cases, need for an immediate intervention in 83 cases.
For the remaining 359 in-born, planned delivery was classiﬁed as
‘potentially justiﬁed’ for the following reasons: possible need for
ductal patency for pulmonary ﬂow in 156 cases, for systemic ﬂow
in 35 cases (3%), incomplete congenital heart disease diagnosis in
94 cases, need to monitor neonatal tolerance of the defect in 51
cases. In these 359 in-born at risk, rationale for planned delivery
was reviewed after birth. A posteriori, it was not necessary for 249
in-born (20%) in whom no intervention was needed during the ﬁrst
week, and conﬁrmed to be necessary for 110 in-born (9%) — 32
in whom diagnosis was different with a direct inﬂuence on man-
agement and with 78 who needed an intervention during the ﬁrst
week.
Conclusions.— Our study demonstrates that only one ﬁfth of foetal
congenital heart diseases delivered in a tertiary reference centre
appears to be unnecessary. Conversely, one third of in-borns with
only possible post-natal risk of cardiac complication were appro-
priately delivered in our institution, as they needed immediate
specialized management.
http://dx.doi.org/10.1016/j.acvd.2013.06.009
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Heart transplantation in young children and infants may be contro-
versial. The aim of this study was to review long-term follow-up
of heart transplanted small children and assess prognosis and out-
comes.
Material and methods.— Patients who underwent orthotopic heart
transplantation (OHT) within the ﬁrst 3 years of life were included
in the study. Demographics, clinical data, events, outcomes and
survival were assessed.
Results.— Among 96 paediatric heart transplantations performed in
a French single-centre, 25 patients who underwent OHT at≤ 3 years
of age, were included in the study (10 males, 15 females). Among
them, 10 (40%) were on VAD support at the time of OHT. Age
at OHT was 1.5± 0.9 years (median 1.2). Underlying cardiac dis-
ease was congenital in four (16%) or idiopathic cardiomyopathy in
21 (84%). Post-transplant follow-up was 7.1± 7 years (range 1day
to 22.7) and was > 10 years in seven cases (28%). Three patients
died at ﬁrst day, second year and fourth year post-transplant.
Mean age of survivors at the time of the study was 9.1± 7.3 years
(range 1.5 to 23.6). One acute rejection episode occurred at ﬁrst
month post-transplant and one at 11th year. One patient had post-
transplant lympho-proliferative disease at 14th year post-transplant
and was successfully cured. Graft coronary disease occurred in
two cases (8%), who underwent second heart and kidney trans-
plantation at 16th and 22nd year after ﬁrst transplant. All other
cases were free from coronary disease with normal graft func-
tion. End-stage renal failure occurred in the two re-transplanted
cases. Signiﬁcant severe renal dysfunction was present in three
cases (no dialysis), moderate in three cases, and 17 had nor-
mal renal function. Linear growth ranged within normal in all
patients, except the two cases with end-stage renal failure, despite
continuous low dose steroid therapy in 80% of the survivors. All
patients are in NYHA class I, except the two re-transplanted cases
who were in NYHA class IV at the time of second transplant.
Patient survival was 96% at 1-year, 90.7% at 3-year and 83% at
10-year post-transplant follow-up. Graft survival was respectively
96%, 90.7%, 83% and 66% at 1-, 3-, 10- and 16-year follow-
up.
Conclusion.— Long-term survival of very young heart transplant
recipient is fairly good, with a low incidence of graft coronary
disease and optimal functional status and growth.
http://dx.doi.org/10.1016/j.acvd.2013.06.010
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Introduction.— A ventricular septal defect (VSD) is part of most
congenital heart defects (CHD).
Aim of the study.— To determine the distribution of the anatomic
types of VSD in CHD.
Material and methods.— We analyzed morphologically 1178 heart
specimens with CHD from the anatomic collection of the French
Reference Center for Complex CHD. Special attention was paid to
the localization of the VSD: muscular, membranous, outlet located
between the two limbs of the septal band, inlet. The specimens
were classiﬁed according to the anatomic and clinical classiﬁcation
of CHD (ACC-CHD).
Results.— A VSD was present in 67% of all hearts and was:
—constant, of a single type, in tetralogy of Fallot and variants
and common arterial trunk: outlet, complete atrioventricu-
lar canal (CAVC): inlet, and double-inlet left ventricle (DILV):
muscular;
—not constant with a predominant type, in 96% of double discord-
ance (inlet 82%), 62% of heterotaxy syndromes (Hetx, inlet 93%) 93%
of interrupted aortic arch (outlet 80%), 87% of double outlet right
ventricle (outlet 77%);
—not constant, of variable type, in 68% of aortic coarctation (CoA:
outlet 44%, membranous 35%, muscular 21%), 54% of transposition
of the great arteries (TGA: outlet 40%, membranous 25%, muscular
25%, inlet 10%);
—rare, in anomalies of pulmonary veins (5%), Ebstein anomaly (14%),
double-inlet right ventricle (10%), coronary anomalies (25%);
—isolated in 10% of all VSD: outlet 44%, membranous 36%, muscular
18%, inlet 2%.
Associations were:
—outlet VSD: 60% ‘‘conotruncal’’ defects (CTD), 10% TGA;
—inlet: 57% CAVC, 13% DD, 10% Hetx;
—muscular: 33% DILV, 26% TGA, 13% isolated;
—membranous: 30% TGA, 28% isolated, 16% CoA.
Conclusion.— The VSD is an integral part of the phenotype in some
CHD (CTD, CAVC, and DILV). In CoA and TGA the VSD is not con-
stant and its anatomic distribution is similar to that in isolated VSD,
indicating a likely random association. This reinforces the hypoth-
esis of different genetic mechanisms in TGA and CTD. This original
approach, using the anatomic characteristics of one part of the phe-
notype, could provide new insights in the grouping and aetiology of
CHD.
http://dx.doi.org/10.1016/j.acvd.2013.06.011
